| Primary |
| Drug Use For Unknown Indication |
30.4% |
| Induction Of Anaesthesia |
8.7% |
| Antibiotic Prophylaxis |
6.5% |
| Infection Prophylaxis |
6.5% |
| Analgesia |
4.3% |
| Analgesic Therapy |
4.3% |
| Knee Arthroplasty |
4.3% |
| Osteomyelitis |
4.3% |
| Pain |
4.3% |
| Prophylaxis |
4.3% |
| Cellulitis |
2.2% |
| Deep Vein Thrombosis |
2.2% |
| Dyspnoea |
2.2% |
| Escherichia Bacteraemia |
2.2% |
| Hypotonia |
2.2% |
| Infection |
2.2% |
| Nausea |
2.2% |
| Preoperative Care |
2.2% |
| Surgery |
2.2% |
| Wound |
2.2% |
|
| Hypotension |
20.0% |
| Haemolytic Anaemia |
8.0% |
| Toxic Skin Eruption |
8.0% |
| Anaphylactic Shock |
4.0% |
| Cardiac Death |
4.0% |
| Hypoprothrombinaemia |
4.0% |
| Medication Error |
4.0% |
| Procedural Complication |
4.0% |
| Rash Erythematous |
4.0% |
| Renal Failure |
4.0% |
| Renal Failure Acute |
4.0% |
| Sepsis Neonatal |
4.0% |
| Small Intestinal Obstruction |
4.0% |
| Spherocytic Anaemia |
4.0% |
| Trigeminal Neuralgia |
4.0% |
| Tryptase Increased |
4.0% |
| Type Iv Hypersensitivity Reaction |
4.0% |
| Urticaria |
4.0% |
| Ventricular Tachycardia |
4.0% |
|
| Secondary |
| Product Used For Unknown Indication |
40.3% |
| Drug Use For Unknown Indication |
10.5% |
| Adult T-cell Lymphoma/leukaemia |
6.8% |
| Ill-defined Disorder |
4.5% |
| Sedation |
4.2% |
| Infection |
3.8% |
| Constipation |
3.5% |
| Hypertension |
3.4% |
| Pyrexia |
3.0% |
| Anaesthesia |
2.7% |
| Antibiotic Therapy |
2.5% |
| Prophylaxis |
2.5% |
| Pain |
1.8% |
| Pneumonia |
1.8% |
| Induction Of Anaesthesia |
1.7% |
| General Anaesthesia |
1.6% |
| Antibiotic Level |
1.5% |
| Drug Therapy |
1.3% |
| Muscle Relaxant Therapy |
1.3% |
| Anaesthesia Procedure |
1.3% |
|
| Drug Rash With Eosinophilia And Systemic Symptoms |
21.1% |
| Toxic Epidermal Necrolysis |
19.5% |
| Diverticulum Intestinal Haemorrhagic |
6.3% |
| Medication Error |
5.5% |
| Anaphylactic Shock |
4.7% |
| Interstitial Lung Disease |
4.7% |
| Urticaria |
4.7% |
| Vestibular Disorder |
4.7% |
| Aspartate Aminotransferase Increased |
3.1% |
| Anaphylactic Reaction |
2.3% |
| Generalised Erythema |
2.3% |
| Granulocytopenia |
2.3% |
| Oesophageal Atresia |
2.3% |
| Pneumonia |
2.3% |
| Premature Rupture Of Membranes |
2.3% |
| Pyrexia |
2.3% |
| Respiratory Arrest |
2.3% |
| Shock |
2.3% |
| Surgery |
2.3% |
| Thrombocytopenia |
2.3% |
|
| Concomitant |
| Product Used For Unknown Indication |
37.0% |
| Drug Use For Unknown Indication |
13.3% |
| Prophylaxis |
13.0% |
| Colitis Ulcerative |
3.9% |
| Hypertension |
3.9% |
| Rheumatoid Arthritis |
3.0% |
| Infection Prophylaxis |
2.9% |
| Constipation |
2.8% |
| Multiple Myeloma |
2.6% |
| Antibiotic Prophylaxis |
2.1% |
| Premedication |
2.1% |
| Supportive Care |
1.8% |
| Bone Marrow Conditioning Regimen |
1.6% |
| Hepatitis C |
1.6% |
| Insomnia |
1.6% |
| Gastritis |
1.5% |
| Pain |
1.3% |
| Diarrhoea |
1.3% |
| Induction Of Anaesthesia |
1.3% |
| Osteoporosis |
1.3% |
|
| Rhabdomyolysis |
8.1% |
| Interstitial Lung Disease |
7.2% |
| White Blood Cell Count Decreased |
7.2% |
| White Blood Cell Count Increased |
7.2% |
| Pancytopenia |
6.8% |
| Liver Disorder |
6.4% |
| Vomiting |
5.9% |
| Pneumonia |
5.1% |
| Renal Failure Acute |
5.1% |
| Death |
4.7% |
| Platelet Count Decreased |
4.2% |
| Renal Impairment |
4.2% |
| Anaemia |
3.8% |
| Diarrhoea |
3.8% |
| Sepsis |
3.8% |
| Thrombocytopenia |
3.8% |
| Pyrexia |
3.4% |
| Skin Ulcer |
3.4% |
| Convulsion |
3.0% |
| Drug Eruption |
3.0% |
|
| Interacting |
| Bronchitis Chronic |
20.0% |
| Gastritis |
20.0% |
| Pneumonia |
20.0% |
| Arrhythmia |
10.0% |
| Atrial Fibrillation |
10.0% |
| Cardiac Failure Chronic |
10.0% |
| Thrombosis Prophylaxis |
10.0% |
|
| Pneumonia Aspiration |
100.0% |
|
